Multiparametric approach using a simple triplex NASBA assay for hormone receptors and HER-2 status in breast cancer tumors.

被引：0
|
作者：
Verjat, T
Lamy, PJ
Servanton, AC
Leissner, P
Grenier, J
Mougin, B
机构：
[1] BioMerieux, Marcy Letoile, France
[2] Ctr Reg Lutte Canc Val DAurelle, Montpellier, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [31] Changes in hormone receptors and Her2 status in the metastases of 21 autopsies in patients with primary breast cancer: A probabilistic approach
    Porras-Reyes, F.
    Sollozo-Dupont, I.
    Bargallo-Rocha, E.
    Villasenor-Navarro, Y.
    Lopez-Estrada, M.
    Suarez-Roa, M. D. L.
    Vaca-Paniagua, F.
    Mejia-Gomez, J.
    Rojas-Cervantes, C.
    Maldonado-Martinez, H. A.
    Perez-Sanchez, V. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S113 - S113
  • [32] Epidemiological risk factors for breast cancer and HER2 overexpression in tumors.
    Swede, H
    Moysich, KB
    Freudenheim, JL
    Quirk, JT
    Muti, PC
    Hurd, T
    Edge, SB
    Winston, JS
    Michalek, AM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S103 - S103
  • [33] The prognostic value of HER-2/neu status in premenopausal patients with hormone-responsive breast cancer.
    Jakesz, R
    Hausmaninger, H
    Kubista, E
    Gnant, M
    Seifert, M
    Kwasny, W
    Steger, G
    Samonigg, H
    Tausch, C
    Stierer, M
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S44 - S44
  • [34] Differences of TILs, hormone receptor, and HER2 status between primary and metastatic tumors.
    Ono, Makiko
    Osako, Tomo
    Taira, Shinichiro
    Shibayama, Tomoko
    Kobayashi, Kokoro
    Kobayashi, Takayuki
    Gomi, Naoya
    Iwase, Takuji
    Ueno, Takayuki
    Ito, Yoshinori
    Ohno, Shinji
    Akiyama, Futoshi
    Takahashi, Shunji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
    Goud, Kalal Iravathy
    Dayakar, Seetha
    Vijayalaxmi, Kolanupaka
    Babu, Saidam Jangu
    Reddy, Vijay Anand P.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 135 (03) : 312 - 317
  • [36] Are the presence of mammographic microcalcifications in breast tumours determined by hormone receptor and HER-2 status?
    Hilton, J. F.
    Bell, D.
    Brezden-Masley, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S165 - S165
  • [37] Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer
    Salvadori, B
    Pinzani, P
    Distante, V
    Casella, D
    Bianchi, S
    Paglierani, M
    Vezzosi, V
    Neumann, R
    Cataliotti, L
    Pazzagli, M
    Orlando, C
    CLINICAL CHEMISTRY, 2005, 51 (01) : 254 - 256
  • [38] Hormone Receptors and HER-2 Status as Surrogates for Histological Subtypes Prognosticate for Disease Control in Node Negative Asian Breast Cancer Patients Treated with Breast Conservation Therapy
    Wong, F.
    Chua, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S183 - S184
  • [39] Hormone Receptors and HER-2 Status as Surrogates for Breast Cancer Molecular Subtypes Prognosticate for Disease Control in Node Negative Asian Patients Treated with Breast Conservation Therapy
    Wong, Fuh Yong
    Chin, Francis K. C.
    Lee, Kuo Ann
    Soong, Yoke Lim
    Chua, Eu Tiong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2011, 40 (02) : 90 - 96
  • [40] Re:: Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
    Spyratos, F
    Bouchet, C
    Ferrero-Poüs, M
    Tubiana-Hulin, M
    Hacène, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) : 1417 - 1418
12345